Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma
Frontiers of Medicine · 2024
DOI: 10.1007/s11684-024-1081-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers of Medicine, 2024. Verfasst von Zhe Nian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China. Hauptthemen laut MEDLINE: Neuroblastoma, Disease Progression, Epithelial-Mesenchymal Transition, Single-Cell Analysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Neuroblastoma (NB) is one of the most common childhood malignancies. Sixty percent of patients present with widely disseminated clinical signs at diagnosis and exhibit poor outcomes. However, the molecular mechanisms triggering NB metastasis remain largely uncharacterized. In this study, we generated a transcriptomic atlas of 15 447 NB cells from eight NB samples, including paired samples of primary tumors and bone marrow metastases. We used time-resolved analysis to chart the evolutionary trajectory of NB cells from the primary tumor to the metastases in the same patient and identified a common 'starter' subpopulation that initiates tumor development and metastasis. The 'starter' population exhibited high expression levels of multiple cell cycle-related genes, indicating the important role of cell cycle upregulation in NB tumor progression. In addition, our evolutionary trajectory analysis demonstrated the involvement of partial epithelial-to-mesenchymal transition (p-EMT) along the metastatic route from the primary site to the bone marrow. Our study provides insights into the program driving NB metastasis and presents a signature of metastasis-initiating cells as an independent prognostic indicator and potential therapeutic target to inhibit the initiation of NB metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
- Zhejiang Key Laboratory of Medical Epigenetics, Department of Cell Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
- Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Cent…
- Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China. zheliu@tmu.edu.cn.
- Zhejiang Key Laboratory of Medical Epigenetics, Department of Cell Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China. zheliu@tmu.edu.cn.
- Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, China. zheliu@tmu.edu.cn.
Zitieren
APA
Nian, Z., Wang, D., Wang, H., Liu, W., Ma, Z., Yan, J., Cao, Y., Li, J., Zhao, Q., & Liu, Z. (2024). Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1081-7
Vancouver
Nian Z, Wang D, Wang H, Liu W, Ma Z, Yan J, et al. Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma. Frontiers of Medicine. 2024. doi:10.1007/s11684-024-1081-7
BibTeX
@article{Nian2024,
author = {Nian, Zhe and Wang, Dan and Wang, Hao and Liu, Wenxu and Ma, Zhenyi and Yan, Jie and Cao, Yanna and Li, Jie and Zhao, Qiang and Liu, Zhe},
title = {Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma},
journal = {Frontiers of Medicine},
year = {2024},
doi = {10.1007/s11684-024-1081-7}
}
EUVIMED